In this study, we identified IGF2BP1, IGF2BP3 and PRMT5 as the bona fide interacting partners of LINC01138 and demonstrated the oncogenic function of the IGF2BP1/IGF2BP3- LINC01138-PRMT5 axis in HCC cells. The gene discussed is LINC01138; the disease is hepatocellular carcinoma.